Lv1
28 积分 2023-03-02 加入
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting
4个月前
已完结
MHC-II-restricted neoantigen vaccine reverses immune microenvironment and overcomes resistance to immune-checkpoint inhibitors in cold tumors
4个月前
已完结
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial
4个月前
已完结
Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial
6个月前
已完结
PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting
6个月前
已完结
Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition
8个月前
已完结
皖公网安备34019202002308
